215 related articles for article (PubMed ID: 10343140)
1. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin.
Gasche C; Dejaco C; Reinisch W; Tillinger W; Waldhoer T; Fueger GF; Lochs H; Gangl A
Digestion; 1999; 60(3):262-7. PubMed ID: 10343140
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia].
Cançado RD; Brasil SA; Noronha TG; Chiattone CS
Rev Assoc Med Bras (1992); 2005; 51(6):323-8. PubMed ID: 16444338
[TBL] [Abstract][Full Text] [Related]
3. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial.
Gasché C; Dejaco C; Waldhoer T; Tillinger W; Reinisch W; Fueger GF; Gangl A; Lochs H
Ann Intern Med; 1997 May; 126(10):782-7. PubMed ID: 9148651
[TBL] [Abstract][Full Text] [Related]
4. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
Krafft A; Breymann C
J Obstet Gynaecol Res; 2011 Feb; 37(2):119-24. PubMed ID: 21159035
[TBL] [Abstract][Full Text] [Related]
5. Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy.
Wali A; Mushtaq A; Nilofer
J Pak Med Assoc; 2002 Sep; 52(9):392-5. PubMed ID: 12532571
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy.
Breymann C; Visca E; Huch R; Huch A
Am J Obstet Gynecol; 2001 Mar; 184(4):662-7. PubMed ID: 11262469
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study.
Valério de Azevedo S; Maltez C; Lopes AI
Scand J Gastroenterol; 2017 Jan; 52(1):29-33. PubMed ID: 27576956
[TBL] [Abstract][Full Text] [Related]
8. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.
Gisbert JP; Bermejo F; Pajares R; Pérez-Calle JL; Rodríguez M; Algaba A; Mancenido N; de la Morena F; Carneros JA; McNicholl AG; González-Lama Y; Maté J
Inflamm Bowel Dis; 2009 Oct; 15(10):1485-91. PubMed ID: 19408339
[TBL] [Abstract][Full Text] [Related]
9. Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).
Kaminsky BM; Pogue KT; Hanigan S; Koelling TM; Dorsch MP
Am J Cardiol; 2016 Jun; 117(12):1942-6. PubMed ID: 27161817
[TBL] [Abstract][Full Text] [Related]
10. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment.
Kulnigg S; Teischinger L; Dejaco C; Waldhör T; Gasche C
Am J Gastroenterol; 2009 Jun; 104(6):1460-7. PubMed ID: 19491860
[TBL] [Abstract][Full Text] [Related]
11. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.
Zilberman M; Silverberg DS; Bits I; Steinbruch S; Wexler D; Sheps D; Schwartz D; Oksenberg A
Am Heart J; 2007 Nov; 154(5):870-6. PubMed ID: 17967592
[TBL] [Abstract][Full Text] [Related]
12. Optimizing preoperative haemoglobin in major orthopaedic surgery using intravenous iron with or without erythropoietin. An epidemiologic study.
Basora M; Colomina MJ; Tio M; Mora L; Sánchez-Etayo G; Salazar F; Ciércoles E; Paños M; Guerrero E; Berge R
Rev Esp Anestesiol Reanim; 2015; 62(6):313-21. PubMed ID: 25698609
[TBL] [Abstract][Full Text] [Related]
13. Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition.
Michaud L; Guimber D; Mention K; Neuville S; Froger H; Gottrand F; Turck D
Clin Nutr; 2002 Oct; 21(5):403-7. PubMed ID: 12381338
[TBL] [Abstract][Full Text] [Related]
14. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
Chuang CL; Liu RS; Wei YH; Huang TP; Tarng DC
Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894
[TBL] [Abstract][Full Text] [Related]
15. Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency.
Bokemeyer B; Krummenerl A; Maaser C; Howaldt S; Mroß M; Mallard N
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):229-238. PubMed ID: 27101422
[TBL] [Abstract][Full Text] [Related]
16. TREATMENT OF ANEMIA AND IMPROVEMENT OF QUALITY OF LIFE AMONG PATIENTS WITH CROHN'S DISEASE: experience using ferric carboxymaltose.
Sobrado CW; Cançado RD; Sobrado LF; Frugis MO; Sobrado MF
Arq Gastroenterol; 2015 Dec; 52(4):255-9. PubMed ID: 26840464
[TBL] [Abstract][Full Text] [Related]
17. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
Riedel MK; Morgenstern T
Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
[TBL] [Abstract][Full Text] [Related]
18. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.
Gasche C; Ahmad T; Tulassay Z; Baumgart DC; Bokemeyer B; Büning C; Howaldt S; Stallmach A;
Inflamm Bowel Dis; 2015 Mar; 21(3):579-88. PubMed ID: 25545376
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia.
Iqbal T; Stein J; Sharma N; Kulnigg-Dabsch S; Vel S; Gasche C
Dig Dis Sci; 2015 May; 60(5):1375-81. PubMed ID: 25501922
[TBL] [Abstract][Full Text] [Related]
20. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
Silverberg DS; Iaina A; Peer G; Kaplan E; Levi BA; Frank N; Steinbruch S; Blum M
Am J Kidney Dis; 1996 Feb; 27(2):234-8. PubMed ID: 8659499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
